Skin and Connective Tissue Diseases: Decubitus ulceration Skin and Connective Tissue Diseases Decubitus ulceration
Conditions
Interventions
The radiographer will be aware of the treatment (ESWT or placebo) and it is likely that the patient may sense some difference between treatments. The Research Nurse carrying out the measurements will
Sponsors
Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Eligibility
Inclusion criteria
Inclusion criteria: All patients in the Royal Hospital for Neuro-disability with decubitus ulceration who do not have exclusion criteria will be included in the study irrespective of age, level of disability or diagnosis. The total number of patients at the Royal Hospital available for the study is expected to be 36.
Exclusion criteria
Exclusion criteria: 1. Those patients who decline to receive treatment after the treatment has been explained to them 2. Those with bleeding disorders or who are on anticoagulant therapy 3. Decubitus ulceration of the chest wall (theoretical risk of lung damage from ESWT) 4. Decubitus ulceration of elbows and elbow creases (uncommon and difficult to access) 5. Ulceration of the ear (uncommon, difficult to access, risk of damage to brain) 6. Over a tumor site
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be the area of pressure sore healed by the end of one month period. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Time to heal 50% 2. Time to complete healing 3. Site of ulceration | — |
Countries
United Kingdom
Outcome results
None listed